XML 37 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity [Abstract]  
Stockholders' Equity
14.          Stockholders’ Equity

In accordance with GAAP, unrecognized prior service costs and net actuarial gains or losses associated with the Company’s pension and postretirement benefit plans and unrealized gains and losses on AFS securities are included in AOCI, net of tax. For the years ended December 31, components of AOCI are:

(In thousands)
  
2024
    
2023
    
2022
  
Unrecognized prior service cost and net actuarial (losses) on pension plans
  
$
(18,103
)
  
$
(21,983
)
  
$
(26,435
)
Unrealized net holding (losses) on AFS securities
    
(123,995
)
    
(138,951
)
    
(163,599
)
AOCI
  
$
(142,098
)
  
$
(160,934
)
  
$
(190,034
)

Certain restrictions exist regarding the ability of the Bank to transfer funds to the Company in the form of cash dividends. The approval of the OCC is required to pay dividends when a bank fails to meet certain minimum regulatory capital standards or when such dividends are in excess of a subsidiary bank’s earnings retained in the current year plus retained net profits for the preceding two years as specified in applicable OCC regulations. At December 31, 2024, approximately $107.6 million of the total stockholders’ equity of the Bank was available for payment of dividends to the Company without approval by the OCC. The Bank’s ability to pay dividends also is subject to the Bank being in compliance with regulatory capital requirements. The Bank is currently in compliance with these requirements. Under the State of Delaware General Corporation Law, the Company may declare and pay dividends either out of accumulated net retained earnings or capital surplus.

The Company purchased 7,600 shares of its common stock during the year ended December 31, 2024, for a total of $0.3 million at an average price of $33.02 per share under its previously announced share repurchase program. On December 18, 2023, the Board of Directors (“Board”) authorized a repurchase program for the Company to repurchase up to 2,000,000 shares of the outstanding shares of its common stock. The Company did not purchase any shares of its common stock during the fourth quarter of 2024. The Company may repurchase shares of its common stock from time to time to mitigate the potential dilutive effects of stock-based incentive plans and other potential uses of common stock for corporate purposes. As of December 31, 2024, there were 1,992,400 shares available for repurchase under this plan authorized on December 18, 2023, which is set to expire on December 31, 2025.